Submission for OMB Review; Comment Request, 63118 [E9-28810]
Download as PDF
63118
Federal Register / Vol. 74, No. 230 / Wednesday, December 2, 2009 / Notices
DEPARTMENT OF AGRICULTURE
Forest Service
Notice of Resource Advisory
Committee Meeting
AGENCY: Lassen Resource Advisory
Committee, Susanville, California,
USDA Forest Service.
ACTION: Notice of meeting.
SUMMARY: Pursuant to the authorities in
the Federal Advisory Committees Act
(Pub. L. 92–463) and under the Secure
Rural Schools and Community SelfDetermination Act of 2000 (Pub. L.
110343) the Lassen County Resource
Advisory Committee will meet
December 10, 2009 in Susanville,
California for a business meeting. The
meeting is open to the public.
SUPPLEMENTARY INFORMATION: The
business meeting on December 10, 2009
will begin at 9 a.m., at the Lassen
National Forest Headquarters Office,
Caribou Conference Room, 2550
Riverside Drive, Susanville, CA 96130.
This meeting will be dedicated to
review and approve agenda, hear public
comments, review October meeting
minutes, review concept papers and
develop a process to invite back for full
proposals. Finish with another public
comment period.
FOR FURTHER INFORMATION CONTACT:
Contact Terri Frolli, Designated Federal
Official, at (530) 257–4188; or Public
Affairs Officer, Heidi Perry, at (530)
252–6604.
Lorene T. Guffey,
Acting Forest Supervisor.
[FR Doc. E9–28735 Filed 12–1–09; 8:45 am]
BILLING CODE 3410–11–M
BROADCASTING BOARD OF
GOVERNORS
mstockstill on DSKH9S0YB1PROD with NOTICES
Sunshine Act Meeting
DATE AND TIME: Wednesday, December 2,
2009, 8 a.m.–9 a.m.
PLACE: Cohen Building, Room 3360, 330
Independence Ave., SW., Washington,
DC 20237.
CLOSED MEETING: The members of the
Broadcasting Board of Governors (BBG)
will meet in a special session to review
and discuss budgetary issues relating to
U.S. Government-funded non-military
international broadcasting. This meeting
is closed because if open it likely would
either disclose matters that would be
properly classified to be kept secret in
the interest of foreign policy under the
appropriate executive order (5 U.S.C.
552b(c)(1)) or would disclose
VerDate Nov<24>2008
18:28 Dec 01, 2009
Jkt 220001
information the premature disclosure of
which would be likely to significantly
frustrate implementation of a proposed
agency action. (5 U.S.C. 552b(c)(9)(B)) In
addition, part of the discussion will
relate solely to the internal personnel
and organizational issues of the BBG or
the International Broadcasting Bureau.
(5 U.S.C. 552b(c)(2) and (6))
CONTACT PERSON FOR MORE INFORMATION:
Persons interested in obtaining more
information should contact Paul
Kollmer-Dorsey at (202) 203–4545.
Paul Kollmer-Dorsey,
Deputy General Counsel.
[FR Doc. E9–28898 Filed 11–30–09; 4:15 pm]
BILLING CODE 8610–01–P
DEPARTMENT OF COMMERCE
Patent and Trademark Office
Submission for OMB Review;
Comment Request
The United States Patent and
Trademark Office (USPTO) will submit
to the Office of Management and Budget
(OMB) for clearance the following
proposal for collection of information
under the provisions of the Paperwork
Reduction Act (44 U.S.C. Chapter 35).
Agency: United States Patent and
Trademark Office (USPTO).
Title: Requirements for Patent
Applications Containing Nucleotide
Sequence and/or Amino Acid Sequence
Disclosures.
Form Number(s): PTO/SB/93.
Agency Approval Number: 0651–
0024.
Type of Request: Revision of a
currently approved collection.
Burden: 103,750 hours annually.
Number of Respondents: 19,750
responses per year.
Average Hours Per Response: The
USPTO estimates that it will take the
public approximately six minutes (0.10
hours) to six hours to gather the
necessary information, prepare the form
or sequence listing, and submit it to the
USPTO.
Needs and Uses: Patent applications
that contain nucleotide and/or amino
acid sequence disclosures must include
a copy of the sequence listing in
accordance with the requirements in 37
CFR 1.821–1.825. Applicants may
submit sequence listings for both U.S.
and international patent applications.
The USPTO uses the sequence listings
during the examination process to
determine the patentability of the
associated patent application. Sequence
listings are also disclosed as part of the
published patent application or issued
PO 00000
Frm 00003
Fmt 4703
Sfmt 4703
patent. Applicants use sequence data
when preparing biotechnology patent
applications and may also search
sequence listings after publication.
Under 37 CFR 1.821(e)–(f), applicants
must also submit a copy of the sequence
listing in ‘‘computer readable form’’
(CRF). If the CRF sequence listing in a
new application is identical to the CRF
sequence listing of another application
that the applicant already has on file at
the USPTO, the applicant may submit a
statement identifying the application
and CRF sequence listing that is already
on file rather than having to submit a
duplicate copy of the CRF listing for the
new application. The USPTO is
proposing to add a new form to this
collection, Request for Transfer of a
Computer Readable Form Under 37 CFR
1.821(e) (PTO/SB/93), in order to assist
customers in submitting this statement.
Affected Public: Businesses or other
for-profits; not-for-profit institutions.
Frequency: On occasion.
Respondent’s Obligation: Required to
obtain or retain benefits.
OMB Desk Officer: Nicholas A. Fraser,
e-mail:
Nicholas_A._Fraser@omb.eop.gov.
Once submitted, the request will be
publicly available in electronic format
through the Information Collection
Review page at https://www.reginfo.gov.
Paper copies can be obtained by:
• E-mail: Susan.Fawcett@uspto.gov.
Include ‘‘0651–0024 Sequence
Disclosures copy request’’ in the subject
line of the message.
• Fax: 571–273–0112, marked to the
attention of Susan K. Fawcett.
• Mail: Susan K. Fawcett, Records
Officer, Office of the Chief Information
Officer, United States Patent and
Trademark Office, P.O. Box 1450,
Alexandria, VA 22313–1450.
Written comments and
recommendations for the proposed
information collection should be sent on
or January 4, 2010 to Nicholas A. Fraser,
OMB Desk Officer, via e-mail at
Nicholas_A._Fraser@omb.eop.gov, or by
fax to 202–395–5167, marked to the
attention of Nicholas A. Fraser.
Dated: November 25, 2009.
Susan K. Fawcett,
Records Officer, USPTO, Office of the Chief
Information Officer.
[FR Doc. E9–28810 Filed 12–1–09; 8:45 am]
BILLING CODE 3510–16–P
E:\FR\FM\02DEN1.SGM
02DEN1
Agencies
[Federal Register Volume 74, Number 230 (Wednesday, December 2, 2009)]
[Notices]
[Page 63118]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-28810]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Patent and Trademark Office
Submission for OMB Review; Comment Request
The United States Patent and Trademark Office (USPTO) will submit
to the Office of Management and Budget (OMB) for clearance the
following proposal for collection of information under the provisions
of the Paperwork Reduction Act (44 U.S.C. Chapter 35).
Agency: United States Patent and Trademark Office (USPTO).
Title: Requirements for Patent Applications Containing Nucleotide
Sequence and/or Amino Acid Sequence Disclosures.
Form Number(s): PTO/SB/93.
Agency Approval Number: 0651-0024.
Type of Request: Revision of a currently approved collection.
Burden: 103,750 hours annually.
Number of Respondents: 19,750 responses per year.
Average Hours Per Response: The USPTO estimates that it will take
the public approximately six minutes (0.10 hours) to six hours to
gather the necessary information, prepare the form or sequence listing,
and submit it to the USPTO.
Needs and Uses: Patent applications that contain nucleotide and/or
amino acid sequence disclosures must include a copy of the sequence
listing in accordance with the requirements in 37 CFR 1.821-1.825.
Applicants may submit sequence listings for both U.S. and international
patent applications. The USPTO uses the sequence listings during the
examination process to determine the patentability of the associated
patent application. Sequence listings are also disclosed as part of the
published patent application or issued patent. Applicants use sequence
data when preparing biotechnology patent applications and may also
search sequence listings after publication.
Under 37 CFR 1.821(e)-(f), applicants must also submit a copy of
the sequence listing in ``computer readable form'' (CRF). If the CRF
sequence listing in a new application is identical to the CRF sequence
listing of another application that the applicant already has on file
at the USPTO, the applicant may submit a statement identifying the
application and CRF sequence listing that is already on file rather
than having to submit a duplicate copy of the CRF listing for the new
application. The USPTO is proposing to add a new form to this
collection, Request for Transfer of a Computer Readable Form Under 37
CFR 1.821(e) (PTO/SB/93), in order to assist customers in submitting
this statement.
Affected Public: Businesses or other for-profits; not-for-profit
institutions.
Frequency: On occasion.
Respondent's Obligation: Required to obtain or retain benefits.
OMB Desk Officer: Nicholas A. Fraser, e-mail: Nicholas_A._Fraser@omb.eop.gov.
Once submitted, the request will be publicly available in
electronic format through the Information Collection Review page at
https://www.reginfo.gov.
Paper copies can be obtained by:
E-mail: Susan.Fawcett@uspto.gov. Include ``0651-0024
Sequence Disclosures copy request'' in the subject line of the message.
Fax: 571-273-0112, marked to the attention of Susan K.
Fawcett.
Mail: Susan K. Fawcett, Records Officer, Office of the
Chief Information Officer, United States Patent and Trademark Office,
P.O. Box 1450, Alexandria, VA 22313-1450.
Written comments and recommendations for the proposed information
collection should be sent on or January 4, 2010 to Nicholas A. Fraser,
OMB Desk Officer, via e-mail at Nicholas_A._Fraser@omb.eop.gov, or by
fax to 202-395-5167, marked to the attention of Nicholas A. Fraser.
Dated: November 25, 2009.
Susan K. Fawcett,
Records Officer, USPTO, Office of the Chief Information Officer.
[FR Doc. E9-28810 Filed 12-1-09; 8:45 am]
BILLING CODE 3510-16-P